Dr. Jayesh Kulkarni has been named one of two inaugural recipients of the NanoMedicines Innovation Network (NMIN) Postdoctoral Award in Targeted Gene Therapy. Dr. Kulkarni, a postdoctoral fellow in the Michael Smith Labs, works under the supervision of Drs. Christian Kastrup and Pieter Cullis on the design of lipid nanoparticles for gene therapy. His work focuses on the biophysical aspects of lipid nanoparticle design, which can be used to create new tools for gene therapy.
The NMIN Postdoctoral Award provides up to $80,000 over two years to exceptional postdoctoral scholars in the field of nanomedicine academic research training with Canadian experts. Provided by the Nanomedicines Innovation Network (NMIN), recipients are selected by members of NMIN’s Research Management Committee.
Additional information about the award, and Dr. Kulkarni’s thoughts on receiving the award, can be found on the NMIN website.